Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHYSOSTIGMINE SALICYLATE CRS (100 MG)

PHYSOSTIGMINE SALICYLATE CRS (100 MG)

57-64-7

DISCOVER
PHYTOMENADIONE CRS (150 MG)

PHYTOMENADIONE CRS (150 MG)

84-80-0

DISCOVER
TRANS-EPOXYPHYTOMENADIONE CRS(5 MG)

TRANS-EPOXYPHYTOMENADIONE CRS(5 MG)

NA

DISCOVER
Primidone

Primidone

125-33-7

DISCOVER
Propranolol D7

Propranolol D7

344298-99-3

DISCOVER
PICOTAMIDE MONOHYDRATE CRS (125 MG)

PICOTAMIDE MONOHYDRATE CRS (125 MG)

80530-63-8

DISCOVER
PICOTAMIDE IMPURITY A CRS (25MG)

PICOTAMIDE IMPURITY A CRS (25MG)

2206-43-1

DISCOVER
Pantoprazole

Pantoprazole

102625-70-7

DISCOVER
PILOCARPINE HYDROCHLORIDE CRS(50 MG)

PILOCARPINE HYDROCHLORIDE CRS(50 MG)

54-71-7

DISCOVER
PILOCARPINE NITRATE CRS (50 MG)

PILOCARPINE NITRATE CRS (50 MG)

148-72-1

DISCOVER
Pseudoephedrine DRUG PRECURSOR

Pseudoephedrine DRUG PRECURSOR

90-82-4

DISCOVER
PIMOZIDE CRS (150 MG)

PIMOZIDE CRS (150 MG)

2062-78-4

DISCOVER